These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5556440)

  • 1. Arginine-vasopressin, lysine-vasopressin, and oxytocin, C14-labeled in the glycine residue.
    Walter R; Havran RT
    Experientia; 1971 Jun; 27(6):645-6. PubMed ID: 5556440
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V
    J Med Chem; 1974 Feb; 17(2):250-2. PubMed ID: 4809260
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological properties of synthetic Ser 4 -Arg 8 -oxytocin (Ile 3 -Ser 4 -arginine vasopressin): role of the residue No. 4 in the hormone-pressor receptor interaction.
    Chauvet J; Chauvet MT; Acher R
    Experientia; 1972 Dec; 28(12):1493-5. PubMed ID: 4347407
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
    Dyckes DF; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1973 Jul; 16(7):843-7. PubMed ID: 4725931
    [No Abstract]   [Full Text] [Related]  

  • 6. Ion-exchange chromatography of oxytocin, arginine-vasopressin, and lysine-vasopressin.
    TAYLOR SP
    Proc Soc Exp Biol Med; 1954 Feb; 85(2):226-8. PubMed ID: 13155555
    [No Abstract]   [Full Text] [Related]  

  • 7. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of desglycinamide lysine vasopressin and its behavioral activity in rats.
    Wang SS
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1511-5. PubMed ID: 5077834
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
    ALI MN
    Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the enzymatic inactivation of arginine vasopressin and oxytocin by rat kidney homogenate.
    Walter R; Shlank H
    Endocrinology; 1975 Mar; 96(3):811-4. PubMed ID: 1116488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved solid-phase method for peptide synthesis--the syntheses of oxytocin and vasopressin.
    Sci Sin; 1975; 18(2):232-41. PubMed ID: 1162326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational flexibility of the neurohypophyseal hormones oxytocin and lysine-vasopressin. A carbon-13 spin-lattice relaxation study of backbone and side chains.
    Deslauriers R; Smith CP; Walter R
    J Am Chem Soc; 1974 Apr; 96(7):2289-91. PubMed ID: 4364949
    [No Abstract]   [Full Text] [Related]  

  • 13. 1,6-Aminosuberic acid analogs of lysine- and arginine-vasopressin and -vasotocin. Synthesis and biological properties.
    Hase S; Sakakibara S; Wahrenburg M; Kirchberger M; Schwartz IL; Walter R
    J Am Chem Soc; 1972 May; 94(10):3590-600. PubMed ID: 5032960
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of polypeptide hormones on lipid monolayers. ii. The effect of insulin analogues, vasopressin, oxytocin, thyrocalcitonin, adrenocorticotropin, and 3',5'-cyclic AMP on the uptake of Ca2+ by monomolecular films of monooctadecyl phosphate.
    Kafka MS; Pak CY
    Biochim Biophys Acta; 1969 Oct; 193(1):117-23. PubMed ID: 4310719
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of neurohypophysial hormones with their antisera.
    Vorherr H; Munsick RA
    J Clin Invest; 1970 Apr; 49(4):828-36. PubMed ID: 5443183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis and pharmacological properties of 4-decarboxamido-8-lysine-vasopressin, 5-decarboxamido-8-lysine-vasopressin, and their 1-deamino analogues.
    Gillessen D; Du Vigneaud V
    J Biol Chem; 1967 Oct; 242(20):4806-12. PubMed ID: 6061422
    [No Abstract]   [Full Text] [Related]  

  • 17. Arginine vasopressin antagonism of oxytocin-stimulated PGE2 release from rabbit amnion cells and the activities of thioanalogs of oxytocin and arginine vasopressin.
    Czaja M; Kruszyński M; Hinko A; Soloff MS
    Pol J Pharmacol; 1994; 46(5):429-37. PubMed ID: 7894530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriferic and hydrosmotic effects of neurohypophysial peptides and their analogues in augmenting fluid uptake by Bufo melanostictus.
    Elliott AB
    J Physiol; 1968 Jul; 197(1):173-82. PubMed ID: 5675041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid, efficient synthesis of oxytocin and 8-arginine-vasopressin. Comparison of benzyl, p-methoxybenzyl, and p-methylbenzyl as protecting groups for cysteine.
    Live DH; Agosta WC; Cowburn D
    J Org Chem; 1977 Oct; 42(22):3556-61. PubMed ID: 915577
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformation of lysine vasopressin: a comparison with oxytocin.
    Walter R; Glickson JD; Schwartz IL; Havran RT; Meienhofer J; Urry DW
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1920-4. PubMed ID: 4505670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.